Vera Therapeutics Ownership 2024 | Who Owns Vera Therapeutics Now?
Institutional Ownership
120.00%
Insider Ownership
7.95%
Retail Ownership
-27.94%
Institutional Holders
166.00
Vera Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | 12.33% | 2.65% | 5,265,000 | 5,265,000 | 100.00% | 227,026,800 | Mar 31, 2024 |
| BLACKROCK INC. | 7.77% | 0.00% | 3,318,964 | 564,070 | 20.48% | 143,113,727 | Mar 31, 2024 |
| COMMODORE CAPITAL LP | 7.41% | 9.13% | 3,165,000 | -2,285,000 | -41.93% | 136,474,800 | Mar 31, 2024 |
| FMR LLC | 7.31% | 0.01% | 3,123,268 | 348,896 | 12.58% | 134,675,317 | Mar 31, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 6.54% | 6.71% | 2,793,987 | -673,169 | -19.42% | 120,476,719 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.60% | 0.01% | 2,393,029 | 2,393,029 | 100.00% | 103,189,000 | Mar 31, 2024 |
| STATE STREET CORP | 5.50% | 0.00% | 2,350,727 | 169,669 | 7.78% | 101,363,348 | Mar 31, 2024 |
| VANGUARD GROUP INC | 5.03% | 0.00% | 2,148,714 | 515,106 | 31.53% | 92,652,547 | Mar 31, 2024 |
| EVERSEPT PARTNERS, LP | 4.27% | 5.25% | 1,823,781 | -91,049 | -4.75% | 78,641,437 | Mar 31, 2024 |
| MORGAN STANLEY | 3.60% | 0.01% | 1,536,790 | 541,950 | 54.48% | 66,266,386 | Mar 31, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 3.58% | 6.89% | 1,526,787 | -2,123,552 | -58.17% | 65,835,055 | Mar 31, 2024 |
| HOLOCENE ADVISORS, LP | 2.83% | 0.19% | 1,207,380 | 1,207,380 | 100.00% | 52,062,226 | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 2.75% | 0.12% | 1,175,148 | 190,824 | 19.39% | 50,672,382 | Mar 31, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 2.37% | 0.05% | 1,011,550 | -316,990 | -23.86% | 43,618,036 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.25% | 0.00% | 961,309 | 178,593 | 22.82% | 41,457,484 | Mar 31, 2024 |
| WOODLINE PARTNERS LP | 2.22% | 0.38% | 947,097 | -1,560,043 | -62.22% | 40,838,823 | Mar 31, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.96% | 0.07% | 837,195 | 837,195 | 100.00% | 36,099,848 | Mar 31, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 1.66% | 12.12% | 710,000 | 95,000 | 15.45% | 30,615,200 | Mar 31, 2024 |
| ORBIMED ADVISORS LLC | 1.58% | 0.54% | 675,872 | -842,243 | -55.48% | 29,143,601 | Mar 31, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 1.58% | 0.15% | 675,000 | -50,000 | -6.90% | 29,106,000 | Mar 31, 2024 |
Vera Therapeutics's largest institutional shareholder is AVORO CAPITAL ADVISORS LLC, holding 12.33% of the company's total share outstanding, currently valued at $227.03M. The top 10 institutional shareholders own together 65.37% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALTIUM CAPITAL MANAGEMENT LP | 1.66% | 12.12% | 710,000 | 95,000 | 15.45% | 30,615,200 | Mar 31, 2024 |
| COMMODORE CAPITAL LP | 7.41% | 9.13% | 3,165,000 | -2,285,000 | -41.93% | 136,474,800 | Mar 31, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 3.58% | 6.89% | 1,526,787 | -2,123,552 | -58.17% | 65,835,055 | Mar 31, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 6.54% | 6.71% | 2,793,987 | -673,169 | -19.42% | 120,476,719 | Mar 31, 2024 |
| EVERSEPT PARTNERS, LP | 4.27% | 5.25% | 1,823,781 | -91,049 | -4.75% | 78,641,437 | Mar 31, 2024 |
| AVORO CAPITAL ADVISORS LLC | 12.33% | 2.65% | 5,265,000 | 5,265,000 | 100.00% | 227,026,800 | Mar 31, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 1.10% | 2.51% | 470,000 | 470,000 | 100.00% | 20,266,400 | Mar 31, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 1.35% | 2.01% | 575,000 | 575,000 | 100.00% | 24,794,000 | Mar 31, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.84% | 1.44% | 360,000 | 360,000 | 100.00% | 15,523,200 | Mar 31, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 1.02% | 1.44% | 436,133 | 436,133 | 100.00% | 18,806,055 | Mar 31, 2024 |
| CARNEGIE MELLON UNIVERSITY | 0.04% | 0.86% | 16,060 | - | - | 692,507 | Mar 31, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.28% | 0.76% | 118,260 | 118,260 | 100.00% | 5,099,371 | Mar 31, 2024 |
| SECTORAL ASSET MANAGEMENT INC | 0.11% | 0.76% | 44,901 | -79,250 | -63.83% | 1,936,131 | Mar 31, 2024 |
| ARTAL GROUP S.A. | 1.18% | 0.56% | 506,019 | 506,019 | 100.00% | 21,819,539 | Mar 31, 2024 |
| ORBIMED ADVISORS LLC | 1.58% | 0.54% | 675,872 | -842,243 | -55.48% | 29,143,601 | Mar 31, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 0.90% | 0.53% | 383,500 | 383,500 | 100.00% | 16,536,520 | Mar 31, 2024 |
| SAMLYN CAPITAL, LLC | 1.51% | 0.47% | 645,501 | 645,501 | 100.00% | 27,834,003 | Mar 31, 2024 |
| EAM INVESTORS, LLC | 0.15% | 0.42% | 62,843 | 62,843 | 100.00% | 2,709,790 | Mar 31, 2024 |
| ALPHABET INC. | 0.56% | 0.41% | 241,264 | -60,316 | -20.00% | 10,403,303 | Mar 31, 2024 |
| WOODLINE PARTNERS LP | 2.22% | 0.38% | 947,097 | -1,560,043 | -62.22% | 40,838,823 | Mar 31, 2024 |
The largest Vera Therapeutics shareholder by % of total assets is ALTIUM CAPITAL MANAGEMENT LP. The company owns 710.00K shares of Vera Therapeutics (VERA), representing 12.12% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | 12.33% | 2.65% | 5,265,000 | 5,265,000 | 100.00% | 227,026,800 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.60% | 0.01% | 2,393,029 | 2,393,029 | 100.00% | 103,189,000 | Mar 31, 2024 |
| HOLOCENE ADVISORS, LP | 2.83% | 0.19% | 1,207,380 | 1,207,380 | 100.00% | 52,062,226 | Mar 31, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.96% | 0.07% | 837,195 | 837,195 | 100.00% | 36,099,848 | Mar 31, 2024 |
| SAMLYN CAPITAL, LLC | 1.51% | 0.47% | 645,501 | 645,501 | 100.00% | 27,834,003 | Mar 31, 2024 |
| READYSTATE ASSET MANAGEMENT LP | 1.39% | 0.36% | 594,091 | 594,091 | 100.00% | 25,617,204 | Mar 31, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 1.35% | 2.01% | 575,000 | 575,000 | 100.00% | 24,794,000 | Mar 31, 2024 |
| BLACKROCK INC. | 7.77% | 0.00% | 3,318,964 | 564,070 | 20.48% | 143,113,727 | Mar 31, 2024 |
| MORGAN STANLEY | 3.60% | 0.01% | 1,536,790 | 541,950 | 54.48% | 66,266,386 | Mar 31, 2024 |
| VANGUARD GROUP INC | 5.03% | 0.00% | 2,148,714 | 515,106 | 31.53% | 92,652,547 | Mar 31, 2024 |
| ARTAL GROUP S.A. | 1.18% | 0.56% | 506,019 | 506,019 | 100.00% | 21,819,539 | Mar 31, 2024 |
| MARSHALL WACE, LLP | 1.13% | 0.03% | 480,519 | 480,519 | 100.00% | 20,719,980 | Mar 31, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 1.10% | 2.51% | 470,000 | 470,000 | 100.00% | 20,266,400 | Mar 31, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 1.02% | 1.44% | 436,133 | 436,133 | 100.00% | 18,806,055 | Mar 31, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1.05% | 0.07% | 446,905 | 430,144 | 2566.34% | 19,270,544 | Mar 31, 2024 |
| D. E. SHAW & CO., INC. | 1.41% | 0.02% | 601,036 | 390,997 | 186.15% | 25,916,672 | Mar 31, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 0.90% | 0.53% | 383,500 | 383,500 | 100.00% | 16,536,520 | Mar 31, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.84% | 1.44% | 360,000 | 360,000 | 100.00% | 15,523,200 | Mar 31, 2024 |
| FMR LLC | 7.31% | 0.01% | 3,123,268 | 348,896 | 12.58% | 134,675,317 | Mar 31, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 0.80% | 0.37% | 341,168 | 341,168 | 100.00% | 14,711,164 | Mar 31, 2024 |
As of Mar 31 2024, Vera Therapeutics's largest institutional buyer is AVORO CAPITAL ADVISORS LLC. The company purchased 5.26M stocks of VERA, valued at $227.03M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COMMODORE CAPITAL LP | 7.41% | 9.13% | 3,165,000 | -2,285,000 | -41.93% | 136,474,800 | Mar 31, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 3.58% | 6.89% | 1,526,787 | -2,123,552 | -58.17% | 65,835,055 | Mar 31, 2024 |
| WOODLINE PARTNERS LP | 2.22% | 0.38% | 947,097 | -1,560,043 | -62.22% | 40,838,823 | Mar 31, 2024 |
| CARLYLE GROUP INC. | - | - | - | -1,438,155 | -100.00% | - | Mar 31, 2024 |
| ORBIMED ADVISORS LLC | 1.58% | 0.54% | 675,872 | -842,243 | -55.48% | 29,143,601 | Mar 31, 2024 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0.82% | 0.02% | 351,653 | -759,307 | -68.35% | 15,163,277 | Mar 31, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 6.54% | 6.71% | 2,793,987 | -673,169 | -19.42% | 120,476,719 | Mar 31, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 2.37% | 0.05% | 1,011,550 | -316,990 | -23.86% | 43,618,036 | Mar 31, 2024 |
| AXA S.A. | 0.64% | 0.04% | 272,078 | -110,613 | -28.90% | 11,732,003 | Mar 31, 2024 |
| EVERSEPT PARTNERS, LP | 4.27% | 5.25% | 1,823,781 | -91,049 | -4.75% | 78,641,437 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 1.31% | 0.00% | 559,790 | -89,428 | -13.77% | 24,138,144 | Mar 31, 2024 |
| UBS OCONNOR LLC | 0.06% | 0.09% | 27,566 | -79,406 | -74.23% | 1,188,646 | Mar 31, 2024 |
| SECTORAL ASSET MANAGEMENT INC | 0.11% | 0.76% | 44,901 | -79,250 | -63.83% | 1,936,131 | Mar 31, 2024 |
| BARCLAYS PLC | 0.10% | 0.00% | 43,568 | -70,179 | -61.70% | 1,879,000 | Mar 31, 2024 |
| ALPHABET INC. | 0.56% | 0.41% | 241,264 | -60,316 | -20.00% | 10,403,303 | Mar 31, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -52,590 | -100.00% | - | Mar 31, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.34% | 0.00% | 146,823 | -51,361 | -25.92% | 6,331,008 | Mar 31, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 1.58% | 0.15% | 675,000 | -50,000 | -6.90% | 29,106,000 | Mar 31, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 0.36% | 0.27% | 153,932 | -46,370 | -23.15% | 6,637,548 | Mar 31, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.04% | 0.00% | 17,732 | -33,190 | -65.18% | 764,604 | Mar 31, 2024 |
As of Mar 31 2024, Vera Therapeutics's biggest institutional seller is COMMODORE CAPITAL LP. The company sold -2.29M shares of VERA, valued at $136.47M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | 12.33% | 2.65% | 5,265,000 | 5,265,000 | 100.00% | 227,026,800 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.60% | 0.01% | 2,393,029 | 2,393,029 | 100.00% | 103,189,000 | Mar 31, 2024 |
| HOLOCENE ADVISORS, LP | 2.83% | 0.19% | 1,207,380 | 1,207,380 | 100.00% | 52,062,226 | Mar 31, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.96% | 0.07% | 837,195 | 837,195 | 100.00% | 36,099,848 | Mar 31, 2024 |
| SAMLYN CAPITAL, LLC | 1.51% | 0.47% | 645,501 | 645,501 | 100.00% | 27,834,003 | Mar 31, 2024 |
| READYSTATE ASSET MANAGEMENT LP | 1.39% | 0.36% | 594,091 | 594,091 | 100.00% | 25,617,204 | Mar 31, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 1.35% | 2.01% | 575,000 | 575,000 | 100.00% | 24,794,000 | Mar 31, 2024 |
| ARTAL GROUP S.A. | 1.18% | 0.56% | 506,019 | 506,019 | 100.00% | 21,819,539 | Mar 31, 2024 |
| MARSHALL WACE, LLP | 1.13% | 0.03% | 480,519 | 480,519 | 100.00% | 20,719,980 | Mar 31, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 1.10% | 2.51% | 470,000 | 470,000 | 100.00% | 20,266,400 | Mar 31, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 1.02% | 1.44% | 436,133 | 436,133 | 100.00% | 18,806,055 | Mar 31, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 0.90% | 0.53% | 383,500 | 383,500 | 100.00% | 16,536,520 | Mar 31, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.84% | 1.44% | 360,000 | 360,000 | 100.00% | 15,523,200 | Mar 31, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 0.80% | 0.37% | 341,168 | 341,168 | 100.00% | 14,711,164 | Mar 31, 2024 |
| LORD, ABBETT & CO. LLC | 0.53% | 0.03% | 225,581 | 225,581 | 100.00% | 9,727,000 | Mar 31, 2024 |
| TD ASSET MANAGEMENT INC | 0.31% | 0.01% | 130,338 | 130,338 | 100.00% | 5,620,175 | Mar 31, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.28% | 0.76% | 118,260 | 118,260 | 100.00% | 5,099,371 | Mar 31, 2024 |
| CANDRIAM S.C.A. | 0.25% | 0.03% | 108,000 | 108,000 | 100.00% | 4,656,960 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.20% | 0.00% | 87,000 | 87,000 | 100.00% | 3,751,440 | Mar 31, 2024 |
| JENNISON ASSOCIATES LLC | 0.18% | 0.00% | 74,939 | 74,939 | 100.00% | 3,231,369 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.16% | 0.00% | 67,700 | 67,700 | 100.00% | 2,919,224 | Mar 31, 2024 |
| EAM INVESTORS, LLC | 0.15% | 0.42% | 62,843 | 62,843 | 100.00% | 2,709,790 | Mar 31, 2024 |
| SEVEN EIGHT CAPITAL, LP | 0.15% | 0.28% | 61,968 | 61,968 | 100.00% | 2,672,060 | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | 0.14% | 0.01% | 60,400 | 60,400 | 100.00% | 2,604,448 | Mar 31, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.09% | 0.01% | 40,000 | 40,000 | 100.00% | 1,724,800 | Mar 31, 2024 |
| STEMPOINT CAPITAL LP | 0.09% | 0.02% | 40,000 | 40,000 | 100.00% | 75,000 | Mar 31, 2024 |
| CAPTRUST FINANCIAL ADVISORS | 0.09% | 0.01% | 37,744 | 37,744 | 100.00% | 1,627,521 | Mar 31, 2024 |
| TUDOR INVESTMENT CORP ET AL | 0.09% | 0.01% | 37,737 | 37,737 | 100.00% | 1,627,219 | Mar 31, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.09% | 0.01% | 37,418 | 37,418 | 100.00% | 1,613,464 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.08% | 0.00% | 34,791 | 34,791 | 100.00% | 1,500,188 | Mar 31, 2024 |
| NOMURA HOLDINGS INC | 0.08% | 0.00% | 32,900 | 32,900 | 100.00% | 1,418,648 | Mar 31, 2024 |
| CAPTION MANAGEMENT, LLC | 0.08% | 0.02% | 32,500 | 32,500 | 100.00% | 1,401,400 | Mar 31, 2024 |
| J. GOLDMAN & CO LP | 0.07% | 0.04% | 30,181 | 30,181 | 100.00% | 1,301,405 | Mar 31, 2024 |
| J. GOLDMAN & CO LP | 0.06% | 0.04% | 27,000 | 27,000 | 100.00% | 1,164,240 | Mar 31, 2024 |
| ARTIA GLOBAL PARTNERS LP | 0.06% | 0.21% | 24,298 | 24,298 | 100.00% | 1,047,730 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.05% | 0.00% | 22,543 | 22,543 | 100.00% | 972,054 | Mar 31, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.05% | 0.00% | 22,179 | 22,179 | 100.00% | 956,000 | Mar 31, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.05% | 0.00% | 20,435 | 20,435 | 100.00% | 881,158 | Mar 31, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.05% | 0.00% | 20,356 | 20,356 | 100.00% | 877,751 | Mar 31, 2024 |
| UBS OCONNOR LLC | 0.05% | 0.01% | 20,000 | 20,000 | 100.00% | 83,000 | Mar 31, 2024 |
| UBS OCONNOR LLC | 0.05% | 0.01% | 20,000 | 20,000 | 100.00% | 97,000 | Mar 31, 2024 |
| FORA CAPITAL, LLC | 0.04% | 0.06% | 16,058 | 16,058 | 100.00% | 692,421 | Mar 31, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.03% | 0.05% | 14,338 | 14,338 | 100.00% | 618,255 | Mar 31, 2024 |
| NOMURA HOLDINGS INC | 0.03% | 0.00% | 13,905 | 13,905 | 100.00% | 599,584 | Mar 31, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | 0.03% | 0.06% | 13,422 | 13,422 | 100.00% | 578,757 | Mar 31, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | 0.03% | 0.00% | 13,100 | 13,100 | 100.00% | 564,872 | Mar 31, 2024 |
| ALGERT GLOBAL LLC | 0.03% | 0.02% | 12,420 | 12,420 | 100.00% | 536,000 | Mar 31, 2024 |
| FRANKLIN RESOURCES INC | 0.03% | 0.00% | 12,284 | 12,284 | 100.00% | 529,686 | Mar 31, 2024 |
| BELVEDERE TRADING LLC | 0.03% | 0.00% | 12,000 | 12,000 | 100.00% | 517,440 | Mar 31, 2024 |
| TREXQUANT INVESTMENT LP | 0.03% | 0.01% | 11,575 | 11,575 | 100.00% | 499,114 | Mar 31, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | 0.03% | 0.00% | 11,147 | 11,147 | 100.00% | 480,659 | Mar 31, 2024 |
| SEI INVESTMENTS CO | 0.03% | 0.00% | 11,109 | 11,109 | 100.00% | 479,018 | Mar 31, 2024 |
| AMERIPRISE FINANCIAL INC | 0.03% | 0.00% | 10,984 | 10,984 | 100.00% | 473,630 | Mar 31, 2024 |
| PROSHARE ADVISORS LLC | 0.03% | 0.00% | 10,885 | 10,885 | 100.00% | 469,362 | Mar 31, 2024 |
| EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. | 0.02% | 0.08% | 10,343 | 10,343 | 100.00% | 445,680 | Mar 31, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0.02% | 0.01% | 10,208 | 10,208 | 100.00% | 440,169 | Mar 31, 2024 |
| ARIZONA STATE RETIREMENT SYSTEM | 0.02% | 0.00% | 8,657 | 8,657 | 100.00% | 373,290 | Mar 31, 2024 |
| E FUND MANAGEMENT CO., LTD. | 0.02% | 0.02% | 8,260 | 8,260 | 100.00% | 356,171 | Mar 31, 2024 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 0.02% | 0.00% | 7,009 | 7,009 | 100.00% | 302,000 | Mar 31, 2024 |
| WEXFORD CAPITAL LP | 0.01% | 0.05% | 6,089 | 6,089 | 100.00% | 262,558 | Mar 31, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | 0.01% | 0.00% | 5,756 | 5,756 | 100.00% | 248,199 | Mar 31, 2024 |
| GTS SECURITIES LLC | 0.01% | 0.00% | 5,601 | 5,601 | 100.00% | 241,515 | Mar 31, 2024 |
| CETERA ADVISORS LLC | 0.01% | 0.00% | 5,460 | 5,460 | 100.00% | 235,435 | Mar 31, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 0.01% | 0.00% | 5,000 | 5,000 | 100.00% | 215,600 | Mar 31, 2024 |
| SIMPLEX TRADING, LLC | 0.01% | 0.00% | 3,329 | 3,329 | 100.00% | 143,000 | Mar 31, 2024 |
| BELVEDERE TRADING LLC | 0.01% | 0.00% | 2,502 | 2,502 | 100.00% | 107,886 | Mar 31, 2024 |
| CAPTION MANAGEMENT, LLC | 0.01% | 0.00% | 2,200 | 2,200 | 100.00% | 94,864 | Mar 31, 2024 |
| 0.00% | 0.00% | 1,988 | 1,988 | 100.00% | 85,711 | Mar 31, 2024 | |
| BELVEDERE TRADING LLC | 0.00% | 0.00% | 1,500 | 1,500 | 100.00% | 64,680 | Mar 31, 2024 |
| CUTLER GROUP LLC / CA | 0.00% | 0.02% | 1,335 | 1,335 | 100.00% | 57,000 | Mar 31, 2024 |
| KBC GROUP NV | 0.00% | 0.00% | 1,090 | 1,090 | 100.00% | 47,000 | Mar 31, 2024 |
| PACER ADVISORS, INC. | 0.00% | 0.00% | 810 | 810 | 100.00% | 34,927 | Mar 31, 2024 |
| COMERICA BANK | 0.00% | - | 48 | 48 | 100.00% | 2,070,000 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | 7 | 7 | 100.00% | 301 | Mar 31, 2024 |
Vera Therapeutics's largest new institutional shareholder by number of shares is AVORO CAPITAL ADVISORS LLC, purchased 5.26M shares, valued at $227.03M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CARLYLE GROUP INC. | - | - | - | -1,438,155 | -100.00% | - | Mar 31, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -52,590 | -100.00% | - | Mar 31, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -28,005 | -100.00% | - | Mar 31, 2024 |
| PALE FIRE CAPITAL SE | - | - | - | -16,389 | -100.00% | - | Mar 31, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -10,430 | -100.00% | - | Mar 31, 2024 |
Vera Therapeutics's largest sold out institutional shareholder by shares sold is CARLYLE GROUP INC., sold -1.44M shares, valued at -, as of undefined.
Vera Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.06% | 160,000 | - | - | Dec 31, 2023 |
| FIDELITY MT VERNON STREET TRUST | 0.04% | 1,263,435 | 61,063 | 5.08% | Feb 29, 2024 |
| FIDELITY CAPITAL TRUST | 0.04% | 465,718 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 20,452 | - | - | Dec 31, 2023 |
| FIDELITY ADVISOR SERIES VII | 0.02% | 211,854 | - | - | Jan 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.02% | 41,859 | 41,859 | - | Feb 29, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.01% | 280,000 | - | - | Feb 29, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,225 | - | - | Dec 31, 2023 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 739,878 | 220,696 | 42.51% | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,536 | 125 | 5.18% | Dec 31, 2023 |
| LORD ABBETT SECURITIES TRUST | 0.01% | 48,383 | 48,383 | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 63,179 | 6,874 | 12.21% | Dec 31, 2023 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 27,727 | 8,291 | 42.66% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 75,000 | - | - | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.00% | 1,904,838 | 562,387 | 41.89% | Dec 31, 2023 |
| Nushares ETF Trust | 0.00% | 29,703 | 2,448 | 8.98% | Jan 31, 2024 |
| ETFis Series Trust I | 0.00% | 5,574 | 5,574 | - | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 25,853 | 25,853 | - | Aug 31, 2023 |
| ALPS ETF Trust | 0.00% | 32,604 | 1,303 | 4.16% | Feb 29, 2024 |
| ProFunds | 0.00% | 18,651 | 8,794 | 89.22% | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 414,106 | 81,751 | 24.60% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 19,868 | 2,864 | 16.84% | Dec 31, 2023 |
| Calvert Variable Products, Inc. | 0.00% | 3,312 | - | - | Dec 31, 2023 |
| FIDELITY COVINGTON TRUST | 0.00% | 18,136 | -3,817 | -17.39% | Feb 29, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 227,845 | 49,169 | 27.52% | Feb 29, 2024 |
| Direxion Shares ETF Trust | 0.00% | 163,944 | 56,841 | 53.07% | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 90,426 | - | - | Jan 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 70,553 | -147,266 | -67.61% | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 8,499 | -699 | -7.60% | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 195,877 | 40,221 | 25.84% | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 16,082 | - | - | Dec 31, 2023 |
| AdvisorShares Trust | 0.00% | 1,403 | - | - | Dec 29, 2023 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 13,762 | - | - | Dec 31, 2023 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,693 | - | - | Dec 31, 2023 |
| Brinker Capital Destinations Trust | 0.00% | 13,548 | 12,927 | 2081.64% | Feb 29, 2024 |
| VANGUARD WORLD FUND | 0.00% | 51,914 | - | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 550 | - | - | Dec 31, 2023 |
| RBB FUND, INC. | 0.00% | 14,182 | 14,182 | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 11,500 | 700 | 6.48% | Dec 31, 2023 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,964 | - | - | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 1,558,085 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 93,246 | -2,021 | -2.12% | Dec 31, 2023 |
| Dimensional ETF Trust | 0.00% | 33,581 | - | - | Jan 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 151,139 | 16,724 | 12.44% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 309 | - | - | Dec 31, 2023 |
| Goldman Sachs ETF Trust | 0.00% | 6,933 | -270 | -3.75% | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 25,670 | 8,471 | 49.25% | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 8,150 | 3,019 | 58.84% | Dec 31, 2023 |
| VALIC Co I | 0.00% | 12,976 | -52 | -0.40% | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,200 | - | - | Dec 29, 2023 |
| SPDR SERIES TRUST | 0.00% | 1,523,786 | 428,691 | 39.15% | Dec 31, 2023 |
| RYDEX DYNAMIC FUNDS | 0.00% | 153 | - | - | Dec 31, 2023 |
| PROSHARES TRUST | 0.00% | 8,878 | 4,507 | 103.11% | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 3,658 | -155 | -4.07% | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 29,297 | -95,300 | -76.49% | Dec 31, 2023 |
| NORTHERN FUNDS | 0.00% | 21,898 | 6,664 | 43.74% | Dec 29, 2023 |
| Pacer Funds Trust | 0.00% | 933 | 933 | - | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 20 | - | - | Dec 31, 2023 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 28,200 | - | - | Dec 31, 2023 |
| Guggenheim Active Allocation Fund | 0.00% | 76 | - | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,189 | - | - | Feb 29, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 45,600 | - | - | Dec 29, 2023 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,831 | -15 | -0.39% | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 10,003 | - | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 13,009 | -503 | -3.72% | Dec 31, 2023 |
| Advisors' Inner Circle Fund III | 0.00% | 88 | 22 | 33.33% | Jan 31, 2024 |
| Columbia Funds Series Trust II | 0.00% | 2,110 | 2,110 | - | Feb 29, 2024 |
| Brighthouse Funds Trust II | 0.00% | 11,588 | - | - | Dec 31, 2023 |
| Franklin Alternative Strategies Funds | 0.00% | 2,420 | 2,420 | - | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 424 | - | - | Feb 29, 2024 |
| PACIFIC SELECT FUND | 0.00% | 12,671 | -70 | -0.55% | Dec 31, 2023 |
| SPDR INDEX SHARES FUNDS | 0.00% | 452 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 9,964 | - | - | Dec 31, 2023 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,073 | - | - | Dec 31, 2023 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 307 | -10 | -3.15% | Dec 31, 2023 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 4,194 | - | - | Dec 31, 2023 |
| John Hancock Funds II | 0.00% | 13,852 | 12,252 | 765.75% | Feb 29, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 16,939 | 10,239 | 152.82% | Feb 29, 2024 |
| T. Rowe Price Multi-Strategy Total Return Fund, Inc. | 0.00% | 45 | 45 | - | Jan 31, 2024 |
Vera Therapeutics's largest mutual fund holder by % of total assets is "VARIABLE INSURANCE PRODUCTS FUND IV", owning 160.00K shares, compromising 0.06% of its total assets.
Vera Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 166 | 74.74% |
| 31 Dec, 23 | 95 | 13.10% |
| 30 Sep, 23 | 84 | 3.70% |
| 30 Jun, 23 | 81 | 15.71% |
| 31 Mar, 23 | 70 | 20.69% |
| 31 Dec, 22 | 58 | 5.45% |
| 30 Sep, 22 | 55 | 10.00% |
| 30 Jun, 22 | 50 | - |
| 31 Mar, 22 | 50 | 35.14% |
| 31 Dec, 21 | 37 | 19.35% |
| 30 Sep, 21 | 31 | 47.62% |
| 30 Jun, 21 | 21 | - |
As of 31 Mar 24, 166 institutions are holding Vera Therapeutics's shares, representing an increase of 74.74% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 51,247,790 | 24.02% |
| 31 Dec, 23 | 41,320,587 | 5.30% |
| 30 Sep, 23 | 39,239,588 | 2.95% |
| 30 Jun, 23 | 38,115,941 | 2.12% |
| 31 Mar, 23 | 37,325,094 | 74.97% |
| 31 Dec, 22 | 21,332,619 | -0.96% |
| 30 Sep, 22 | 21,539,850 | 5.61% |
| 30 Jun, 22 | 20,394,973 | 3.66% |
| 31 Mar, 22 | 19,674,561 | 39.98% |
| 31 Dec, 21 | 14,054,792 | -4.46% |
| 30 Sep, 21 | 14,710,733 | 1.36% |
| 30 Jun, 21 | 14,513,290 | - |
Vera Therapeutics (VERA) has 51.25M shares outstanding as of 31 Mar 24, up 24.02% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 120.00% | 1.38% |
| 31 Dec, 23 | 93.14% | 1.19% |
| 30 Sep, 23 | 88.64% | 0.87% |
| 30 Jun, 23 | 101.19% | 1.03% |
| 31 Mar, 23 | 99.09% | 1.54% |
| 31 Dec, 22 | 80.29% | 1.28% |
| 30 Sep, 22 | 79.14% | 1.40% |
| 30 Jun, 22 | 75.32% | 1.14% |
| 31 Mar, 22 | 81.21% | 1.86% |
| 31 Dec, 21 | 66.06% | 1.38% |
| 30 Sep, 21 | 69.14% | 0.36% |
| 30 Jun, 21 | 138.22% | - |
As of 31 Mar 24, Vera Therapeutics is held by 120.00% institutional shareholders, representing a 1.38% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 121 | 128.30% |
| 31 Dec, 23 | 53 | -1.85% |
| 30 Sep, 23 | 54 | 5.88% |
| 30 Jun, 23 | 51 | 2.00% |
| 31 Mar, 23 | 50 | 56.25% |
| 31 Dec, 22 | 32 | - |
| 30 Sep, 22 | 32 | 28.00% |
| 30 Jun, 22 | 25 | -34.21% |
| 31 Mar, 22 | 38 | 40.74% |
| 31 Dec, 21 | 27 | 17.39% |
| 30 Sep, 21 | 23 | 9.52% |
| 30 Jun, 21 | 21 | - |
121 institutional shareholders have increased their position in VERA stock as of 31 Mar 24 compared to 53 in the previous quarter (a 128.30% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 30 | 42.86% |
| 31 Dec, 23 | 21 | 40.00% |
| 30 Sep, 23 | 15 | -25.00% |
| 30 Jun, 23 | 20 | 122.22% |
| 31 Mar, 23 | 9 | -30.77% |
| 31 Dec, 22 | 13 | 44.44% |
| 30 Sep, 22 | 9 | -18.18% |
| 30 Jun, 22 | 11 | 37.50% |
| 31 Mar, 22 | 8 | 60.00% |
| 31 Dec, 21 | 5 | 66.67% |
| 30 Sep, 21 | 3 | - |
| 30 Jun, 21 | - | - |
30 institutional shareholders have reduced their position in VERA stock as of 31 Mar 24 compared to 21 in the previous quarter (a 42.86% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 166 | 74.74% | 51,247,790 | 24.02% | 120.00% | 1.38% | 121 | 128.30% | 30 | 42.86% |
| 31 Dec, 23 | 95 | 13.10% | 41,320,587 | 5.30% | 93.14% | 1.19% | 53 | -1.85% | 21 | 40.00% |
| 30 Sep, 23 | 84 | 3.70% | 39,239,588 | 2.95% | 88.64% | 0.87% | 54 | 5.88% | 15 | -25.00% |
| 30 Jun, 23 | 81 | 15.71% | 38,115,941 | 2.12% | 101.19% | 1.03% | 51 | 2.00% | 20 | 122.22% |
| 31 Mar, 23 | 70 | 20.69% | 37,325,094 | 74.97% | 99.09% | 1.54% | 50 | 56.25% | 9 | -30.77% |
| 31 Dec, 22 | 58 | 5.45% | 21,332,619 | -0.96% | 80.29% | 1.28% | 32 | - | 13 | 44.44% |
| 30 Sep, 22 | 55 | 10.00% | 21,539,850 | 5.61% | 79.14% | 1.40% | 32 | 28.00% | 9 | -18.18% |
| 30 Jun, 22 | 50 | - | 20,394,973 | 3.66% | 75.32% | 1.14% | 25 | -34.21% | 11 | 37.50% |
| 31 Mar, 22 | 50 | 35.14% | 19,674,561 | 39.98% | 81.21% | 1.86% | 38 | 40.74% | 8 | 60.00% |
| 31 Dec, 21 | 37 | 19.35% | 14,054,792 | -4.46% | 66.06% | 1.38% | 27 | 17.39% | 5 | 66.67% |
| 30 Sep, 21 | 31 | 47.62% | 14,710,733 | 1.36% | 69.14% | 0.36% | 23 | 9.52% | 3 | - |
| 30 Jun, 21 | 21 | - | 14,513,290 | - | 138.22% | - | 21 | - | - | - |
Vera Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Vera Therapeutics's stock was made by Young Joseph R on May 17 2024, selling 20,651 shares at $7.87 per share (valued at $162.52K).
Vera Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 11 | 27 | 40.74% |
| Q1 2024 | 9 | 9 | 100.00% |
| Q4 2023 | 2 | 3 | 66.67% |
| Q3 2023 | 2 | 5 | 40.00% |
| Q2 2023 | 9 | - | - |
| Q1 2023 | 30 | 1 | 3000.00% |
| Q4 2022 | 18 | 21 | 85.71% |
| Q3 2022 | 8 | 22 | 36.36% |
| Q2 2022 | 14 | 6 | 233.33% |
| Q1 2022 | 10 | - | - |
| Q4 2021 | 1 | 1 | 100.00% |
| Q3 2021 | 1 | 1 | 100.00% |
| Q2 2021 | 28 | 24 | 116.67% |
| Q3 2013 | - | 7 | - |
| Q2 2013 | 1 | 1 | 100.00% |
| Q1 2013 | 1 | 1 | 100.00% |
| Q4 2012 | - | 1 | - |
| Q2 2012 | 2 | - | - |
| Q2 2011 | 1 | - | - |
| Q3 2010 | 1 | - | - |
11 total buy trades, and 27 total sell trades (buy/sell ratio of 0.41%) were made by Vera Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 24 | - |
| Q1 2024 | 1 | 7 | 14.29% |
| Q4 2023 | - | - | - |
| Q3 2023 | - | 3 | - |
| Q2 2023 | 2 | - | - |
| Q1 2023 | 24 | - | - |
| Q4 2022 | - | 8 | - |
| Q3 2022 | - | 14 | - |
| Q2 2022 | 4 | 3 | 133.33% |
| Q1 2022 | 5 | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | 7 | - | - |
| Q3 2013 | - | - | - |
| Q2 2013 | - | - | - |
| Q1 2013 | - | - | - |
| Q4 2012 | - | - | - |
| Q2 2012 | - | - | - |
| Q2 2011 | - | - | - |
| Q3 2010 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 24 open market sell trades of Vera Therapeutics's stocks.
Vera Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| ANEB | Anebulo Pharmaceuticals, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| ANAB | AnaptysBio, Inc. |
| DICE | DICE Therapeutics, Inc. |
| VTYX | Ventyx Biosciences, Inc. |
| TYRA | Tyra Biosciences, Inc. |
| TVTX | Travere Therapeutics, Inc. |
| THRD | Third Harmonic Bio, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| ACRV | Acrivon Therapeutics, Inc. Common Stock |
| LIAN | LianBio |
| CGEM | Cullinan Oncology, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| COGT | Cogent Biosciences, Inc. |
| ETON | Eton Pharmaceuticals, Inc. |
| ALDX | Aldeyra Therapeutics, Inc. |
| CNTB | Connect Biopharma Holdings Limited |
| TARS | Tarsus Pharmaceuticals, Inc. |
| RLYB | Rallybio Corporation |
| XLO | Xilio Therapeutics, Inc. |
| ADAG | Adagene Inc. |
| CYTK | Cytokinetics, Incorporated |
| RAPT | RAPT Therapeutics, Inc. |
VERA Ownership FAQ
Who Owns Vera Therapeutics?
Vera Therapeutics is owned by institutional shareholders (120.00%), insiders (7.95%), and public (-27.94%). The largest institutional shareholder of Vera Therapeutics is AVORO CAPITAL ADVISORS LLC (12.33% of total shares) and the top mutual fund owner is VARIABLE INSURANCE PRODUCTS FUND IV (0.06% of total shares).
Who are the major institutional shareholders of Vera Therapeutics?
Vera Therapeutics's major institutional shareholders are AVORO CAPITAL ADVISORS LLC, BLACKROCK INC., COMMODORE CAPITAL LP, FMR LLC, and SOFINNOVA INVESTMENTS, INC.. The top five shareholders own together 41.37% of the company's share outstanding.
How many Vera Therapeutics shareholders are there?
As of Mar 2024, there are 166 institutional shareholders of Vera Therapeutics.
What percentage of Vera Therapeutics is owned by AVORO CAPITAL ADVISORS LLC?
AVORO CAPITAL ADVISORS LLC owns 5.26M shares of Vera Therapeutics, representing 12.33% of the company's total shares outstanding, valued at $227.03M (as of Mar 2024).
What percentage of Vera Therapeutics is owned by BLACKROCK INC?
As of Mar 2024, BLACKROCK INC holds 3.32M shares of Vera Therapeutics (VERA), compromising 7.77% of the company, valued at $143.11M.
What percentage of Vera Therapeutics is owned by COMMODORE CAPITAL LP?
COMMODORE CAPITAL LP is the third largest holder of Vera Therapeutics. The company owns 3.16M of the company's shares outstanding (worth $136.47M).